AMRXAmneal Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Amneal Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMRX본 종목 | $5.8B#7 | 38.1x#2 | 176.7x#11 | 1.9x#1 | 8.0%#7 | 161.6%#3 | 13.1%#3 | 218.2%#1 | 14.6%#1 | 6#1 | 90.0%#6 | — |
| RYTM | $6.8B#1 | — | 66.3x#10 | 36.0x#6 | 45.8%#6 | 24.6%#8 | -101.2%#8 | -0.2%#5 | -133.8%#7 | — | 3.1%#11 | — |
| MIRM | $6.4B#2 | — | — | 12.2x#3 | 54.7%#5 | 73.4%#5 | -4.2%#4 | — | — | — | 34.2%#9 | — |
| ORKA | $6.3B#3 | — | 5.7x#4 | — | — | -25.9%#11 | — | -9.5%#7 | — | — | 490.3%#2 | — |
| LQDA | $6.1B#5 | 48.4x#3 | 31.1x#9 | 38.3x#7 | 1031.2%#1 | 47.1%#7 | -32.5%#7 | -35.3%#11 | — | — | — | — |
| TVTX | $6.1B#4 | — | 247.6x#12 | 12.4x#4 | 110.5%#3 | 92.1%#4 | -12.8%#5 | -104.2%#13 | — | — | 172.2%#3 | — |
| GOSS | $5.9B#6 | — | — | 121.8x#8 | -57.7%#9 | -201.4%#15 | -352.2%#9 | — | — | — | -95.0%#13 | — |
| AMRN | — | — | — | — | -6.5%#8 | 55.4%#6 | -23.5%#6 | -8.7%#6 | -16.2%#3 | — | -7.3%#12 | — |
| COGT | $5.7B#8 | — | 10.7x#6 | 726.4x#9 | -65.0%#10 | -28.6%#12 | -4235.3%#10 | -61.8%#12 | -84.3%#6 | — | 166.7%#4 | — |
| DNTH | $5.6B#11 | — | 4.8x#3 | 2760.5x#11 | -67.3%#11 | -91.1%#14 | -8739.3%#12 | -13.9%#8 | — | — | 158.4%#5 | — |
| PTCT | $5.6B#10 | — | — | 3.3x#2 | 114.5%#2 | 288.0%#2 | 50.1%#1 | — | — | — | 11.3%#10 | — |
| LGND | $5.7B#9 | 29.2x#1 | 5.9x#5 | 21.1x#5 | 60.4%#4 | 3186.6%#1 | 15.3%#2 | 12.9%#2 | 3.0%#2 | — | 71.6%#7 | — |
| XENE | $5.6B#12 | — | 4.5x#1 | 741.4x#10 | — | -47.6%#13 | -4974.3%#11 | -27.8%#9 | -32.5%#4 | — | 56.5%#8 | — |
| ERAS | $5.3B#13 | — | 14.7x#8 | — | — | 23.0%#9 | — | -34.4%#10 | — | — | 814.1%#1 | — |
| EWTX | $5.0B#14 | — | 11.1x#7 | — | — | -25.4%#10 | — | -0.0%#4 | -50.9%#5 | — | — | — |
| PBLS | $4.8B#15 | — | 4.6x#2 | — | — | — | — | 0.0%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice